Anti stress agent!

Oxidative stress refers to the situations in which the body’s antioxidant and other defensive abilities to combat free radicals (a.k.a highly reactive species of oxygen and nitrogen) are overwhelmed and one’s normal healthy balance is either lost or severely compromised. products include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates.

 http://www.oxis.com

This blog post deals about the oxidative stress discovered by OXIS International, Inc. is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress.” We focus on naturally occurring protective substances since they are more likely to be both safe and efficacious. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L- Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process 

Oxis on Twitter

Oxis on facebook

Bio Engneering technology:

The Group's principal activity is to own and license the N-Viro Processes, patented technologies to treat and recycle wastewater and other bio-organic wastes utilizing certain alkaline and mineral by-products produced by the cement, lime, electric utilities and other industries. It operates in four segments:The single most critical cost component to every beneficial use option is the ability to get as much water out of the biosolids as possible in the dewatering process. An investment into state-of-the-art dewatering equipment is always worth the analysis. Management Operations provides employee and management services to operate the Toledo Ohio Wastewater Treatment Facility and the Daytona/Volusia County Florida Treatment Facility.http://www.nviro.com
Other Domestic Operations includes sales of territory or site licenses and royalty fees to use N-Viro technology in the United States. Foreign Operations includes sale of territory or site licenses and royalty fees to use N-Viro technology in foreign operations. Research and Development, the Group contracts with Federal and State agencies to perform or assist in research and development on the Group's technology
The N-Viro process can receive biosolids as low as 12% solids, however, the higher the solids the better. Dependent upon facility design biosolids can be received directly from dewatering into the processor, tipped onto a receiving floor, or delivered into a receiving bin. A key aspect regarding receiving is the process allows for a wide spot in the line which allows operators to run the equipment automatically which enables more time to focus on the efficiencies of dewatering